Clinical Trials Browser

Neoplasms × zimberelimab × 90 days × Clear all

NCT06759649 2026-02-27

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Phase 1 Recruiting

Neoplasms